[HTML][HTML] Prevention, screening, treatment and follow-up of gynecological cancers: state of art and future perspectives

TG D'Augè, A Giannini, G Bogani, C Di Dio… - Clinical and …, 2023 - imrpress.com
Objective: This study aims to analyze the available data on prevention and early diagnosis
in gynecological cancers. Mechanism: A comprehensive search was performed in the …

Recent developments in human papillomavirus (HPV) vaccinology

AL Williamson - Viruses, 2023 - mdpi.com
Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization

A Giannini, V Di Donato, F Sopracordevole, A Ciavattini… - Vaccines, 2023 - mdpi.com
The objective of this work is to assess the 5-year outcomes of patients undergoing
conization for high-grade cervical lesions that simultaneously present as risk factors in the …

Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia

G Bogani, F Sopracordevole, A Ciavattini… - European Journal of …, 2023 - journals.lww.com
Objective To evaluate how the duration of human papillomavirus (HPV) persistence
influences the risk of developing recurrent high-grade cervical dysplasia (CIN2+). Methods …

[HTML][HTML] The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for …

V Kesic, X Carcopino, M Preti… - Journal of lower …, 2023 - journals.lww.com
Abstract The European Society of Gynaecological Oncology (ESGO), the International
Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study …

Development of a nomogram predicting the risk of persistence/recurrence of cervical dysplasia

G Bogani, L Lalli, F Sopracordevole, A Ciavattini… - Vaccines, 2022 - mdpi.com
Background: Cervical dysplasia persistence/recurrence has a great impact on women's
health and quality of life. In this study, we investigated whether a prognostic nomogram may …

Human papillomavirus epidemiology and prevention: is there still a gender gap?

G Milano, G Guarducci, N Nante, E Montomoli, I Manini - Vaccines, 2023 - mdpi.com
Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: a focus on the potential role of vaccination

G Bogani, F Sopracordevole, A Ciavattini… - Tumori …, 2024 - journals.sagepub.com
Objective: To date, no data supports the execution of vaccination after hysterectomy for high-
grade cervical intraepithelial neoplasia (CIN2+) and early-stage cervical cancer. We aim to …

Digital health interventions to improve adolescent HPV vaccination: a systematic review

J Choi, I Tami-Maury, P Cuccaro, S Kim, C Markham - Vaccines, 2023 - mdpi.com
Digital technologies are being increasingly utilized in healthcare to provide pertinent and
timely information for primary prevention, such as vaccination. This study aimed to conduct a …

British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023

J Morrison, P Baldwin, L Hanna, A Andreou… - European Journal of …, 2024 - Elsevier
Evidence was searched in the Cochrane Central Register of Controlled Trials (CENTRAL,
The Cochrane Library April 2022, Issue 4), MEDLINE and EMBASE up to April 2022, with …